Olema Pharmaceuticals, Inc.
OLMA
$27.45
$0.301.11%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 49.57% | -6.75% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 21.16% | 8.58% | |||
| Operating Income | -21.16% | -8.58% | |||
| Income Before Tax | 3.58% | -44.08% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 3.58% | -44.08% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 3.58% | -44.08% | |||
| EBIT | -21.16% | -8.58% | |||
| EBITDA | -21.47% | -8.60% | |||
| EPS Basic | 3.85% | -43.97% | |||
| Normalized Basic EPS | -24.62% | -11.11% | |||
| EPS Diluted | 3.85% | -43.97% | |||
| Normalized Diluted EPS | -24.62% | -11.11% | |||
| Average Basic Shares Outstanding | 0.27% | 0.08% | |||
| Average Diluted Shares Outstanding | 0.27% | 0.08% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||